400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
ChiCTR2000032894
尚未开始
/
/
/
2020-05-15
/
/
腦性麻痺
鬆筋手術與股骨生長板抑制術對腦性麻痺髖關節脫位的療效比較
鬆筋手術與股骨生長板抑制術對腦性麻痺髖關節脫位的療效比較
This study is to reject a hypothesis that decrease in MP after soft tissue release and guided growth is the same as decrease in MP after soft tissue release in spastic hip displacement with MP 30% to 70%. The study purposes are 1) to validate therapeutic role of guided growth in spastic hip displacement and 2) to determine the patients who benefits most from the use of guided growth.
析因分组(即根据危险因素或暴露因素分组)
其它
病例回溯研究
N/A
科技部
/
50
/
2019-09-02
2020-06-30
/
It is a retrospective comparative study comprised of children with spastic CP who underwent soft tissue release with or without guided growth for hip displacement from June 2005 to September 2016. Hip displacement was defined by a Reimers MP greater than 30%. We excluded children with a pre-operative MP greater than 70%, those underwent open reduction of the hip or osteotomy of femur or pelvis, and those with post-operative follow up of less than 2 years.;
请登录查看無意願參加試驗追蹤者;
请登录查看林口長庚兒童骨科
/
英百瑞生物2025-12-05
艾力斯医药科技2025-12-05
神曦生物NeuExcell2025-12-05
科望医药2025-12-05
宠药生态圈2025-12-05
丁香园 Insight 数据库2025-12-05
佰傲谷BioValley2025-12-05
药精通Bio2025-12-05
医药观澜2025-12-05
贝达药业2025-12-05